-
1741por Pennisi, Marzio“…The treatment is directed against melanoma in B16 OVA mouse models exposed to a specific immunotherapy strategy. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1742por Bergeron, Marjorie-Allison, Champagne, Sophie, Gaudreault, Manon, Deschambeault, Alexandre, Landreville, Solange“…PURPOSE: Uveal melanoma (UM) has been the subject of intense interest due to its distinctive metastatic pattern, which involves hematogenous dissemination of cancerous cells toward the liver in 50% of patients. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1743por Pécuchet, N, Lebbe, C, Mir, O, Billemont, B, Blanchet, B, Franck, N, Viguier, M, Coriat, R, Tod, M, Avril, M-F, Goldwasser, F“…This study reports long-term pharmacokinetic monitoring of patients treated with sorafenib and a retrospective pharmacodynamic/pharmacokinetic analysis in melanoma patients. PATIENTS AND METHODS: Heavily pretreated patients with stage IV melanoma were started on sorafenib 400 mg twice daily (bid). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1744por Kim, Young JinEnlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1745“…In the present study, we show that merlin knockdown enhances melanoma cell proliferation, migration, and invasion in vitro and that decreased merlin expression promotes subcutaneous melanoma growth in immunocompromised mice. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1746por Kumar, Suresh M., Zhang, Gao, Bastian, Boris C., Arcasoy, Murat O., Karande, Pankaj, Pushparajan, Anitha, Acs, Geza, Xu, Xiaowei“…In this study, we demonstrated that EpoR mRNA expression was detectable in 90.1% of 65 melanoma cell lines, and increased copy number of the Epo and EpoR loci occurred in 30% and 24.6% of 130 primary melanomas, respectively. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1747por Đorđić, Marija, Matić, Ivana Z, Filipović-Lješković, Ivana, Džodić, Radan, Šašić, Miomir, Erić-Nikolić, Aleksandra, Vuletić, Ana, Kolundžija, Branka, Damjanović, Ana, Grozdanić, Nađa, Nikolić, Srđan, Pralica, Janko, Dobrosavljević, Danijela, Rašković, Sanvila, Andrejević, Slađana, Juranić, Zorica“…BACKGROUND: The aim of this study was to determine the presence and the intensity of humoral immunity to melanoma-associated antigens: tyrosinase and melanin, in patients with melanoma, in persons with vitiligo and in control healthy people. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1748“…This drug has been used successfully in the clinic to treat metastatic melanoma patients harboring B-Raf mutations.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1749“…Here, we summarize recent efforts to characterize intra-tumoral heterogeneity of melanoma and delineate key questions for future studies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1750“…In the present paper, we summarize the latest trends in dermoscopy concerning early melanoma diagnosis, management of nodular lesions, diagnosis of mucosal melanoma, and digital followup.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1751por Lee, Hyoun Wook, Song, Ki Hoon, Hong, Jin Woo, Jeon, Su Young, Ko, Dong Yeob, Kim, Ki Ho, Kwon, Hyuk Chan, Lee, Suee, Kim, Sung Hyun, Kim, Dae Cheol“…BACKGROUND: This study was conducted to clarify the frequency of the BRAF mutation in primary melanomas and its correlation with clinicopathologic parameters. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1752por Hadrup, Sine Reker“…Large numbers of tumor associated antigens has been characterized, but only a minor fraction of these are recognized by tumor infiltrating lymphocytes of melanoma, although these have shown the ability to recognize tumor and provide tumor regression upon adoptive transfer. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1753“…Recently, a CTLA-4 antibody and BRAF inhibitors showed survival benefits in advance melanoma treatment. The documentation of immune infiltrates in melanomas early during BRAF inhibitor therapy provides a scientific rationale for combination therapy with both treatments with possible synergistic benefits. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1754por Reuland, Steven N., Goldstein, Nathaniel B., Partyka, Katie A., Smith, Shilo, Luo, Yuchun, Fujita, Mayumi, Gonzalez, Rene, Lewis, Karl, Norris, David A., Shellman, Yiqun G.“…The Bcl-2 family modulates sensitivity to anticancer drugs in many cancers, including melanomas. In this study, we examined whether ABT-737 is effective in killing melanoma cells either alone or in combination with a proteasome inhibitor already in clinical use (Bortezomib) in vitro and in vivo, and further evaluated the mechanisms of action. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1755por Salvianti, Francesca, Pinzani, Pamela, Verderio, Paolo, Ciniselli, Chiara Maura, Massi, Daniela, De Giorgi, Vincenzo, Grazzini, Marta, Pazzagli, Mario, Orlando, Claudio“…The aim of the present study was to identify a sequential multi-marker panel in cfDNA able to increase the predictive capability in the diagnosis of cutaneous melanoma in comparison with each single marker alone. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1756por Herman, Cila“…Every year around 2.5–3 million skin lesions are biopsied in the US, and a fraction of these – between 50,000 and 100,000 – are diagnosed as melanoma. Diagnostic instruments that allow early detection of melanoma are the key to improving survival rates and reducing the number of unnecessary biopsies, the associated morbidity, and the costs of care. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1757“…Melanoma is the leading cause of fatal skin cancer, and in the past few decades, there has been an increase in the incidence of and mortality from metastatic melanoma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1758por Cagnini, Didier Q, Salgado, Breno S, Linardi, Juliana L, Grandi, Fabrizio, Rocha, Rafael M, Rocha, Noeme S, Teixeira, Carlos R, Del Piero, Fabio, Sequeira, Julio L“…CASE PRESENTATION: An ocular melanoma and a mammary mucinous carcinoma are described in an African lion (Panthera leo). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1759por Purwar, Rahul, Schlapbach, Christoph, Xiao, Sheng, Kang, Hong Soon, Elyaman, Wassim, Jiang, Xiaodong, Jetten, Anton M, Khoury, Samia J., Fuhlbrigge, Robert C, Kuchroo, Vijay K, Clark, Rachael A, Kupper, Thomas S“…We determined that T cells from mice deficient in the T(H)17 pathway genes ROR-γ and IL-23R produced abundant IL-9, and observed significant growth inhibition of B16F10 melanoma tumor in these mice. IL-9 blocking antibodies reversed this tumor growth inhibition, and enhanced tumor growth in normal mice. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1760“…We report a case of choroidal melanoma with massive extraocular extensions through the sclera. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto